{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T07:10:01Z","timestamp":1780902601490,"version":"3.54.1"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100010804","name":"Faculty of Medicine, Prince of Songkla University","doi-asserted-by":"publisher","award":["356\/63-00646"],"award-info":[{"award-number":["356\/63-00646"]}],"id":[{"id":"10.13039\/501100010804","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Education & Public Welfare"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-77762-3","type":"journal-article","created":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T04:41:15Z","timestamp":1730436075000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Prevalence and implications of fragile X premutation screening in Thailand"],"prefix":"10.1038","volume":"14","author":[{"given":"Areerat","family":"Hnoonual","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunita","family":"Kaewfai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanin","family":"Limwongse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pornprot","family":"Limprasert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,1]]},"reference":[{"key":"77762_CR1","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1097\/GIM.0b013e3181e38fb6","volume":"12","author":"MK Hill","year":"2010","unstructured":"Hill, M. K., Archibald, A. D., Cohen, J. & Metcalfe, S. A. A systematic review of population screening for fragile X syndrome. Genet. Med. 12, 396\u2013410 (2010).","journal-title":"Genet. Med."},{"key":"77762_CR2","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1002\/ajmg.a.36511","volume":"164A","author":"J Hunter","year":"2014","unstructured":"Hunter, J. et al. Epidemiology of fragile X syndrome: A systematic review and meta-analysis. Am. J. Med. Genet. A 164A, 1648\u20131658 (2014).","journal-title":"Am. J. Med. Genet. A"},{"key":"77762_CR3","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1866-1955-6-24","volume":"6","author":"CM Yrigollen","year":"2014","unstructured":"Yrigollen, C. M. et al. AGG interruptions and maternal age affect FMR1 CGG repeat allele stability during transmission. J. Neurodev. Disord. 6, 24 (2014).","journal-title":"J. Neurodev. Disord."},{"key":"77762_CR4","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/gim.2014.106","volume":"17","author":"SL Nolin","year":"2015","unstructured":"Nolin, S. L. et al. Fragile X full mutation expansions are inhibited by one or more AGG interruptions in premutation carriers. Genet. Med. 17, 358\u2013364 (2015).","journal-title":"Genet. Med."},{"key":"77762_CR5","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41436-021-01115-y","volume":"23","author":"E Spector","year":"2021","unstructured":"Spector, E. et al. Laboratory testing for fragile X, 2021 revision: A technical standard of the American College of Medical Genetics and Genomics (ACMG). Genet Med 23, 799\u2013812 (2021).","journal-title":"Genet Med"},{"key":"77762_CR6","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.3390\/cells12182330","volume":"12","author":"F Tassone","year":"2023","unstructured":"Tassone, F. et al. Insight and recommendations for fragile X-premutation-associated conditions from the fifth international conference on FMR1 premutation. Cells 12, 2330 (2023).","journal-title":"Cells"},{"key":"77762_CR7","doi-asserted-by":"publisher","DOI":"10.1111\/jar.13214","volume":"37","author":"K Johnson","year":"2024","unstructured":"Johnson, K. et al. A holistic approach to fragile X syndrome integrated guidance for person-centred care. J. Appl. Res. Intellect. Disabil. 37, e13214 (2024).","journal-title":"J. Appl. Res. Intellect. Disabil."},{"key":"77762_CR8","doi-asserted-by":"publisher","first-page":"74","DOI":"10.4238\/vol7-1gmr357","volume":"7","author":"AHO Reis","year":"2008","unstructured":"Reis, A. H. O. et al. Frequency of FMR1 premutation in individuals with ataxia and\/or tremor and\/or parkinsonism. Genet. Mol. Res. 7, 74\u201384 (2008).","journal-title":"Genet. Mol. Res."},{"key":"77762_CR9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1744-9081-7-19","volume":"7","author":"AI Seixas","year":"2011","unstructured":"Seixas, A. I. et al. FXTAS is rare among Portuguese patients with movement disorders: FMR1 premutations may be associated with a wider spectrum of phenotypes. Behav. Brain Funct. 7, 19 (2011).","journal-title":"Behav. Brain Funct."},{"key":"77762_CR10","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s12311-021-01323-x","volume":"21","author":"Y Higuchi","year":"2022","unstructured":"Higuchi, Y. et al. Prevalence of fragile X-associated tremor\/ataxia syndrome in patients with cerebellar Ataxia in Japan. Cerebellum 21, 851\u2013860 (2022).","journal-title":"Cerebellum"},{"key":"77762_CR11","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/j.parkreldis.2014.07.001","volume":"20","author":"M Faruq","year":"2014","unstructured":"Faruq, M. et al. Identification of FXTAS presenting with SCA 12 like phenotype in India. Parkinsonism Relat. Disord. 20, 1089\u20131093 (2014).","journal-title":"Parkinsonism Relat. Disord."},{"key":"77762_CR12","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1212\/01.WNL.0000130199.57181.7B","volume":"63","author":"EK Tan","year":"2004","unstructured":"Tan, E. K. et al. Fragile X premutation alleles in SCA, ET, and parkinsonism in an Asian cohort. Neurology 63, 362\u2013363 (2004).","journal-title":"Neurology"},{"key":"77762_CR13","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/sj.ejhg.5201312","volume":"13","author":"H Van Esch","year":"2005","unstructured":"Van Esch, H. et al. Screening for FMR-1 premutations in 122 older Flemish males presenting with ataxia. Eur. J. Hum. Genet. 13, 121\u2013123 (2005).","journal-title":"Eur. J. Hum. Genet."},{"key":"77762_CR14","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s00439-003-0939-z","volume":"112","author":"J Macpherson","year":"2003","unstructured":"Macpherson, J., Waghorn, A., Hammans, S. & Jacobs, P. Observation of an excess of fragile-X premutations in a population of males referred with spinocerebellar ataxia. Hum. Genet. 112, 619\u2013620 (2003).","journal-title":"Hum. Genet."},{"key":"77762_CR15","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1007\/s12311-021-01329-5","volume":"21","author":"A Almansour","year":"2022","unstructured":"Almansour, A. et al. Frequency of FMR1 premutation alleles in patients with undiagnosed cerebellar ataxia and multiple system atrophy in the japanese population. Cerebellum 21, 954\u2013962 (2022).","journal-title":"Cerebellum"},{"key":"77762_CR16","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1080\/01616412.2020.1863697","volume":"43","author":"M Pe\u0161i\u0107","year":"2021","unstructured":"Pe\u0161i\u0107, M. et al. Premutations in the FMR1 gene in Serbian patients with undetermined tremor, ataxia and parkinsonism. Neurol. Res. 43, 321\u2013326 (2021).","journal-title":"Neurol. Res."},{"key":"77762_CR17","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/ajmg.a.30761","volume":"136","author":"AI Seixas","year":"2005","unstructured":"Seixas, A. I. et al. FXTAS, SCA10, and SCA17 in American patients with movement disorders. Am. J. Med. Genet. A 136, 87\u201389 (2005).","journal-title":"Am. J. Med. Genet. A"},{"key":"77762_CR18","first-page":"497","volume":"42","author":"M Rajkiewicz","year":"2008","unstructured":"Rajkiewicz, M. et al. Screening for premutation in the FMR1 gene in male patients suspected of spinocerebellar ataxia. Neurol. Neurochir. Pol. 42, 497\u2013504 (2008).","journal-title":"Neurol. Neurochir. Pol."},{"key":"77762_CR19","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1080\/01677060701686242","volume":"22","author":"SA Adams","year":"2008","unstructured":"Adams, S. A., Steenblock, K. J., Thibodeau, S. N. & Lindor, N. M. Premutations in the FMR1 gene are uncommon in men undergoing genetic testing for spinocerebellar ataxia. J. Neurogenet. 22, 77\u201392 (2008).","journal-title":"J. Neurogenet."},{"key":"77762_CR20","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1002\/ajmg.a.20465","volume":"125A","author":"JM Milunsky","year":"2004","unstructured":"Milunsky, J. M. & Maher, T. A. Fragile X carrier screening and spinocerebellar ataxia in older males. Am. J. Med. Genet. A 125A, 320 (2004).","journal-title":"Am. J. Med. Genet. A"},{"key":"77762_CR21","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1007\/s12035-007-0020-3","volume":"35","author":"L Rodriguez-Revenga","year":"2007","unstructured":"Rodriguez-Revenga, L. et al. FXTAS in Spanish patients with ataxia: Support for female FMR1 premutation screening. Mol. Neurobiol. 35, 324\u2013328 (2007).","journal-title":"Mol. Neurobiol."},{"key":"77762_CR22","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1001\/archneur.63.8.1135","volume":"63","author":"E Cellini","year":"2006","unstructured":"Cellini, E. et al. Fragile X premutation with atypical symptoms at onset. Arch. Neurol. 63, 1135\u20131138 (2006).","journal-title":"Arch. Neurol."},{"key":"77762_CR23","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1212\/01.WNL.0000148723.37489.3F","volume":"64","author":"A Brussino","year":"2005","unstructured":"Brussino, A. et al. FMR1 gene premutation is a frequent genetic cause of late-onset sporadic cerebellar ataxia. Neurology 64, 145\u2013147 (2005).","journal-title":"Neurology"},{"key":"77762_CR24","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1007\/s00415-004-0558-1","volume":"251","author":"C Z\u00fchlke","year":"2004","unstructured":"Z\u00fchlke, C. et al. FMR1 premutation as a rare cause of late onset ataxia\u2013evidence for FXTAS in female carriers. J. Neurol. 251, 1418\u20131419 (2004).","journal-title":"J. Neurol."},{"key":"77762_CR25","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1097\/01.GIM.0000182468.22666.dd","volume":"7","author":"S Sherman","year":"2005","unstructured":"Sherman, S., Pletcher, B. A. & Driscoll, D. A. Fragile X syndrome: Diagnostic and carrier testing. Genet. Med. 7, 584\u2013587 (2005).","journal-title":"Genet. Med."},{"key":"77762_CR26","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1097\/AOG.0b013e3181fae884","volume":"116","author":"American College of Obstetricians and Gynecologists Committee on Genetics","year":"2010","unstructured":"American College of Obstetricians and Gynecologists Committee on Genetics. ACOG committee opinion No. 469: Carrier screening for fragile X syndrome. Obstet. Gynecol. 116, 1008\u20131010 (2010).","journal-title":"Obstet. Gynecol."},{"key":"77762_CR27","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/gim.2017.134","volume":"20","author":"AD Archibald","year":"2018","unstructured":"Archibald, A. D. et al. Reproductive genetic carrier screening for cystic fibrosis, fragile X syndrome, and spinal muscular atrophy in Australia: Outcomes of 12,000 tests. Genet Med 20, 513\u2013523 (2018).","journal-title":"Genet Med"},{"key":"77762_CR28","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1002\/pd.1815","volume":"27","author":"M Berkenstadt","year":"2007","unstructured":"Berkenstadt, M., Ries-Levavi, L., Cuckle, H., Peleg, L. & Barkai, G. Preconceptional and prenatal screening for fragile X syndrome: Experience with 40,000 tests. Prenat. Diagn 27, 991\u2013994 (2007).","journal-title":"Prenat. Diagn"},{"key":"77762_CR29","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s10897-016-0005-3","volume":"26","author":"R Alfaro Arenas","year":"2017","unstructured":"Alfaro Arenas, R., Rosell Andreo, J., Heine Su\u00f1er, D., Group for the study of FXS in the Balearic Islands. A pilot study of fragile X syndrome screening in pregnant women and women planning pregnancy: Implementation, acceptance, awareness, and geographic factors. J. Genet. Couns. 26, 501\u2013510 (2017).","journal-title":"J. Genet. Couns."},{"key":"77762_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.1024","volume":"7","author":"K Johansen Taber","year":"2019","unstructured":"Johansen Taber, K., Lim-Harashima, J., Naemi, H. & Goldberg, J. Fragile X syndrome carrier screening accompanied by genetic consultation has clinical utility in populations beyond those recommended by guidelines. Mol. Genet. Genomic Med. 7, e1024 (2019).","journal-title":"Mol. Genet. Genomic Med."},{"key":"77762_CR31","doi-asserted-by":"publisher","first-page":"17065","DOI":"10.1038\/nrdp.2017.65","volume":"3","author":"RJ Hagerman","year":"2017","unstructured":"Hagerman, R. J. et al. Fragile X syndrome. Nat. Rev. Dis. Primers 3, 17065 (2017).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"77762_CR32","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1002\/ajmg.a.38692","volume":"176","author":"KM Owens","year":"2018","unstructured":"Owens, K. M. et al. FMR1 premutation frequency in a large, ethnically diverse population referred for carrier testing. Am. J. Med. Genet. A 176, 1304\u20131308 (2018).","journal-title":"Am. J. Med. Genet. A"},{"key":"77762_CR33","doi-asserted-by":"publisher","first-page":"9206","DOI":"10.3390\/ijms24119206","volume":"24","author":"C-G Ciobanu","year":"2023","unstructured":"Ciobanu, C.-G. et al. Narrative review: Update on the molecular diagnosis of fragile X syndrome. Int J Mol Sci.\u00a024, 9206 (2023).","journal-title":"Int J Mol Sci."},{"key":"77762_CR34","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-024-03242-2","author":"Q Ain","year":"2024","unstructured":"Ain, Q. et al. Population-based FMR1 carrier screening among reproductive women. J. Assist. Reprod. Genet. https:\/\/doi.org\/10.1007\/s10815-024-03242-2 (2024).","journal-title":"J. Assist. Reprod. Genet."},{"key":"77762_CR35","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1086\/321974","volume":"69","author":"H Toledano-Alhadef","year":"2001","unstructured":"Toledano-Alhadef, H. et al. Fragile-X carrier screening and the prevalence of premutation and full-mutation carriers in Israel. Am. J. Hum. Genet. 69, 351\u2013360 (2001).","journal-title":"Am. J. Hum. Genet."},{"key":"77762_CR36","doi-asserted-by":"publisher","first-page":"4359308","DOI":"10.1155\/2021\/4359308","volume":"2021","author":"A Hnoonual","year":"2021","unstructured":"Hnoonual, A., Jankittunpaiboon, C. & Limprasert, P. Screening for FMR1 CGG repeat expansion in Thai patients with autism spectrum disorder. Biomed. Res. Int. 2021, 4359308 (2021).","journal-title":"Biomed. Res. Int."},{"key":"77762_CR37","volume-title":"Mutation Screening and Association Study of the FMR1 Gene in Thai Patient with Autism","author":"C Jankittunpaiboon","year":"2008","unstructured":"Jankittunpaiboon, C. Mutation Screening and Association Study of the FMR1 Gene in Thai Patient with Autism (Prince of Songkla University, 2008)."},{"key":"77762_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2023.117728","volume":"553","author":"A Hnoonual","year":"2024","unstructured":"Hnoonual, A., Plong-On, O., Worachotekamjorn, J., Charalsawadi, C. & Limprasert, P. Clinical and molecular characteristics of FMR1 microdeletion in patient with fragile X syndrome and review of the literature. Clin. Chim. Acta 553, 117728 (2024).","journal-title":"Clin. Chim. Acta"},{"key":"77762_CR39","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1001\/jama.1993.03510130075034","volume":"270","author":"WT Brown","year":"1993","unstructured":"Brown, W. T. et al. Rapid fragile X carrier screening and prenatal diagnosis using a nonradioactive PCR test. JAMA 270, 1569\u20131575 (1993).","journal-title":"JAMA"},{"key":"77762_CR40","first-page":"1057","volume":"88","author":"C Charalsawadi","year":"2005","unstructured":"Charalsawadi, C., Sripo, T. & Limprasert, P. Multiplex methylation specific PCR analysis of fragile X syndrome: Experience in Songklanagarind Hospital. J. Med. Assoc. Thai. 88, 1057\u20131061 (2005).","journal-title":"J. Med. Assoc. Thai."},{"key":"77762_CR41","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2353\/jmoldx.2008.070073","volume":"10","author":"F Tassone","year":"2008","unstructured":"Tassone, F., Pan, R., Amiri, K., Taylor, A. K. & Hagerman, P. J. A rapid polymerase chain reaction-based screening method for identification of all expanded alleles of the fragile X (FMR1) gene in newborn and high-risk populations. J. Mol. Diagn. 10, 43\u201349 (2008).","journal-title":"J. Mol. Diagn."},{"key":"77762_CR42","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2003.012716","volume":"41","author":"Y Zhou","year":"2004","unstructured":"Zhou, Y. et al. Robust fragile X (CGG)n genotype classification using a methylation specific triple PCR assay. J. Med. Genet. 41, e45 (2004).","journal-title":"J. Med. Genet."},{"key":"77762_CR43","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1111\/j.1469-1809.2011.00694.x","volume":"76","author":"E Peprah","year":"2012","unstructured":"Peprah, E. Fragile X syndrome: The FMR1 CGG repeat distribution among world populations. Ann. Hum. Genet. 76, 178\u2013191 (2012).","journal-title":"Ann. Hum. Genet."},{"key":"77762_CR44","first-page":"1252","volume":"59","author":"SL Nolin","year":"1996","unstructured":"Nolin, S. L. et al. Familial transmission of the FMR1 CGG repeat. Am. J. Hum. Genet. 59, 1252\u20131261 (1996).","journal-title":"Am. J. Hum. Genet."},{"key":"77762_CR45","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ogc.2010.03.004","volume":"37","author":"TJ Musci","year":"2010","unstructured":"Musci, T. J. & Moyer, K. Prenatal carrier testing for fragile X: Counseling issues and challenges. Obstet. Gynecol. Clin. North Am. 37, 61\u201370 (2010).","journal-title":"Obstet. Gynecol. Clin. North Am."},{"key":"77762_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta7160","volume":"7","author":"FJ Song","year":"2003","unstructured":"Song, F. J., Barton, P., Sleightholme, V., Yao, G. L. & Fry-Smith, A. Screening for fragile X syndrome: A literature review and modelling study. Health Technol. Assess 7, 1\u2013106 (2003).","journal-title":"Health Technol. Assess"},{"key":"77762_CR47","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.jgg.2021.04.012","volume":"48","author":"Q Guo","year":"2021","unstructured":"Guo, Q. et al. Population-based carrier screening and prenatal diagnosis of fragile X syndrome in East Asian populations. J. Genet. Genom. 48, 1104\u20131110 (2021).","journal-title":"J. Genet. Genom."},{"key":"77762_CR48","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1097\/01.GIM.0000086480.69309.1E","volume":"5","author":"D Skinner","year":"2003","unstructured":"Skinner, D., Sparkman, K. L. & Bailey, D. B. Screening for Fragile X Syndrome: Parent attitudes and perspectives. Genet. Med. 5, 378\u2013384 (2003).","journal-title":"Genet. Med."},{"key":"77762_CR49","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1002\/ajmg.a.32725","volume":"149A","author":"K Acharya","year":"2009","unstructured":"Acharya, K. & Ross, L. F. Fragile X screening: Attitudes of genetic health professionals. Am. J. Med. Genet. A 149A, 626\u2013632 (2009).","journal-title":"Am. J. Med. Genet. A"},{"key":"77762_CR50","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s12687-024-00696-w","volume":"15","author":"Y Zhu","year":"2024","unstructured":"Zhu, Y. et al. Attitudes of medical professionals toward fragile X carrier screening and genetic counseling in China. J. Commun. Genet. 15, 177\u2013185 (2024).","journal-title":"J. Commun. Genet."},{"key":"77762_CR51","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/gim.2015.55","volume":"18","author":"J Zlotogora","year":"2016","unstructured":"Zlotogora, J., Grotto, I., Kaliner, E. & Gamzu, R. The Israeli national population program of genetic carrier screening for reproductive purposes. Genet. Med. 18, 203\u2013206 (2016).","journal-title":"Genet. Med."},{"key":"77762_CR52","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1038\/s41436-020-0807-4","volume":"22","author":"M Westemeyer","year":"2020","unstructured":"Westemeyer, M. et al. Clinical experience with carrier screening in a general population: Support for a comprehensive pan-ethnic approach. Genet. Med. 22, 1320\u20131328 (2020).","journal-title":"Genet. Med."},{"key":"77762_CR53","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1086\/367713","volume":"72","author":"SL Nolin","year":"2003","unstructured":"Nolin, S. L. et al. Expansion of the fragile X CGG repeat in females with premutation or intermediate alleles. Am. J. Hum. Genet. 72, 454\u2013464 (2003).","journal-title":"Am. J. Hum. Genet."},{"key":"77762_CR54","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1002\/pd.2815","volume":"31","author":"SL Nolin","year":"2011","unstructured":"Nolin, S. L. et al. Fragile X analysis of 1112 prenatal samples from 1991 to 2010. Prenat. Diagn. 31, 925\u2013931 (2011).","journal-title":"Prenat. Diagn."},{"key":"77762_CR55","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1002\/ajmg.a.61165","volume":"179","author":"SL Nolin","year":"2019","unstructured":"Nolin, S. L. et al. Expansions and contractions of the FMR1 CGG repeat in 5,508 transmissions of normal, intermediate, and premutation alleles. Am. J. Med. Genet. A 179, 1148\u20131156 (2019).","journal-title":"Am. J. Med. Genet. A"},{"key":"77762_CR56","first-page":"1006","volume":"57","author":"F Rousseau","year":"1995","unstructured":"Rousseau, F., Rouillard, P., Morel, M. L., Khandjian, E. W. & Morgan, K. Prevalence of carriers of premutation-size alleles of the FMRI gene\u2013and implications for the population genetics of the fragile X syndrome. Am. J. Hum. Genet. 57, 1006\u20131018 (1995).","journal-title":"Am. J. Hum. Genet."},{"key":"77762_CR57","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/j.1399-0004.2009.01237.x","volume":"76","author":"S L\u00e9vesque","year":"2009","unstructured":"L\u00e9vesque, S. et al. Screening and instability of FMR1 alleles in a prospective sample of 24,449 mother-newborn pairs from the general population. Clin. Genet. 76, 511\u2013523 (2009).","journal-title":"Clin. Genet."},{"key":"77762_CR58","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/GIM.0b013e3181fa9fad","volume":"13","author":"FM Hantash","year":"2011","unstructured":"Hantash, F. M. et al. FMR1 premutation carrier frequency in patients undergoing routine population-based carrier screening: Insights into the prevalence of fragile X syndrome, fragile X-associated tremor\/ataxia syndrome, and fragile X-associated primary ovarian insufficiency in the United States. Genet. Med. 13, 39\u201345 (2011).","journal-title":"Genet. Med."},{"key":"77762_CR59","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/gm401","volume":"4","author":"F Tassone","year":"2012","unstructured":"Tassone, F. et al. FMR1 CGG allele size and prevalence ascertained through newborn screening in the United States. Genome Med. 4, 100 (2012).","journal-title":"Genome Med."},{"key":"77762_CR60","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1002\/1097-0223(200008)20:8<611::AID-PD881>3.0.CO;2-M","volume":"20","author":"R Pesso","year":"2000","unstructured":"Pesso, R. et al. Screening for fragile X syndrome in women of reproductive age. Prenat. Diagn. 20, 611\u2013614 (2000).","journal-title":"Prenat. Diagn."},{"key":"77762_CR61","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/1096-8628(20000717)93:2<155::AID-AJMG13>3.0.CO;2-G","volume":"93","author":"V Drasinover","year":"2000","unstructured":"Drasinover, V. et al. Increased transmission of intermediate alleles of the FMR1 gene compared with normal alleles among female heterozygotes. Am. J. Med. Genet. 93, 155\u2013157 (2000).","journal-title":"Am. J. Med. Genet."},{"key":"77762_CR62","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1089\/10906570050501524","volume":"4","author":"E Geva","year":"2000","unstructured":"Geva, E. et al. The risk of fragile X premutation expansion is lower in carriers detected by general prenatal screening than in carriers from known fragile X families. Genet. Test 4, 289\u2013292 (2000).","journal-title":"Genet. Test"},{"key":"77762_CR63","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/BF00216445","volume":"92","author":"T Arinami","year":"1993","unstructured":"Arinami, T., Asano, M., Kobayashi, K., Yanagi, H. & Hamaguchi, H. Data on the CGG repeat at the fragile X site in the non-retarded Japanese population and family suggest the presence of a subgroup of normal alleles predisposing to mutate. Hum. Genet. 92, 431\u2013436 (1993).","journal-title":"Hum. Genet."},{"key":"77762_CR64","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.braindev.2008.12.015","volume":"32","author":"S Otsuka","year":"2010","unstructured":"Otsuka, S. et al. Fragile X carrier screening and FMR1 allele distribution in the Japanese population. Brain Dev. 32, 110\u2013114 (2010).","journal-title":"Brain Dev."},{"key":"77762_CR65","first-page":"204","volume":"66","author":"K-F Huang","year":"2003","unstructured":"Huang, K.-F. et al. Original article pilot screening for fragile X carrier in pregnant women of southern Taiwan. J. Chin. Med. Assoc. 66, 204\u2013209 (2003).","journal-title":"J. Chin. Med. Assoc."},{"key":"77762_CR66","first-page":"12","volume":"102","author":"JC Chow","year":"2003","unstructured":"Chow, J. C. et al. Feasibility of blood spot PCR in large-scale screening of fragile X syndrome in southern Taiwan. J. Formos. Med. Assoc. 102, 12\u201316 (2003).","journal-title":"J. Formos. Med. Assoc."},{"key":"77762_CR67","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/ajmg.a.30528","volume":"133A","author":"C-C Tzeng","year":"2005","unstructured":"Tzeng, C.-C. et al. Prevalence of the FMR1 mutation in Taiwan assessed by large-scale screening of newborn boys and analysis of DXS548-FRAXAC1 haplotype. Am. J. Med. Genet. A 133A, 37\u201343 (2005).","journal-title":"Am. J. Med. Genet. A"},{"key":"77762_CR68","doi-asserted-by":"publisher","first-page":"15456","DOI":"10.1038\/s41598-019-51726-4","volume":"9","author":"C-C Hung","year":"2019","unstructured":"Hung, C.-C. et al. Fragile X syndrome carrier screening in pregnant women in Chinese Han population. Sci. Rep. 9, 15456 (2019).","journal-title":"Sci. Rep."},{"key":"77762_CR69","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1177\/0969141313488364","volume":"20","author":"MJ Kim","year":"2013","unstructured":"Kim, M. J. et al. Fragile X carrier screening in Korean women of reproductive age. J. Med. Screen 20, 15\u201320 (2013).","journal-title":"J. Med. Screen"},{"key":"77762_CR70","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/cge.12195","volume":"85","author":"J-H Jang","year":"2014","unstructured":"Jang, J.-H. et al. Frequency of FMR1 premutation carriers and rate of expansion to full mutation in a retrospective diagnostic FMR1 Korean sample. Clin. Genet. 85, 441\u2013445 (2014).","journal-title":"Clin. Genet."},{"key":"77762_CR71","first-page":"110","volume":"23","author":"YK Cheng","year":"2017","unstructured":"Cheng, Y. K. et al. Identification of fragile X pre-mutation carriers in the Chinese obstetric population using a robust FMR1 polymerase chain reaction assay: Implications for screening and prenatal diagnosis. Hong Kong Med. J. 23, 110\u2013116 (2017).","journal-title":"Hong Kong Med. J."},{"key":"77762_CR72","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1002\/mgg3.128","volume":"3","author":"W Huang","year":"2015","unstructured":"Huang, W. et al. Distribution of fragile X mental retardation 1 CGG repeat and flanking haplotypes in a large Chinese population. Mol. Genet. Genomic Med. 3, 172\u2013181 (2015).","journal-title":"Mol. Genet. Genomic Med."},{"key":"77762_CR73","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12881-019-0805-z","volume":"20","author":"Y Ma","year":"2019","unstructured":"Ma, Y. et al. The prevalence of CGG repeat expansion mutation in FMR1 gene in the northern Chinese women of reproductive age. BMC Med. Genet. 20, 81 (2019).","journal-title":"BMC Med. Genet."},{"key":"77762_CR74","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.1236","volume":"8","author":"F Gao","year":"2020","unstructured":"Gao, F. et al. Development of Chinese genetic reference panel for Fragile X Syndrome and its application to the screen of 10,000 Chinese pregnant women and women planning pregnancy. Mol. Genet. Genomic Med. 8, e1236 (2020).","journal-title":"Mol. Genet. Genomic Med."},{"key":"77762_CR75","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1093\/humrep\/deh635","volume":"20","author":"AK Sullivan","year":"2005","unstructured":"Sullivan, A. K. et al. Association of FMR1 repeat size with ovarian dysfunction. Hum. Reprod. 20, 402\u2013412 (2005).","journal-title":"Hum. Reprod."},{"key":"77762_CR76","doi-asserted-by":"publisher","first-page":"306","DOI":"10.2353\/jmoldx.2009.080174","volume":"11","author":"I Fernandez-Carvajal","year":"2009","unstructured":"Fernandez-Carvajal, I. et al. Expansion of an FMR1 grey-zone allele to a full mutation in two generations. J. Mol. Diagn. 11, 306\u2013310 (2009).","journal-title":"J. Mol. Diagn."},{"key":"77762_CR77","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1002\/mds.24021","volume":"27","author":"D Hall","year":"2012","unstructured":"Hall, D., Tassone, F., Klepitskaya, O. & Leehey, M. Fragile X-associated tremor ataxia syndrome in FMR1 gray zone allele carriers. Mov. Disord. 27, 296\u2013300 (2012).","journal-title":"Mov. Disord."},{"key":"77762_CR78","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/cge.12026","volume":"84","author":"Y Liu","year":"2013","unstructured":"Liu, Y., Winarni, T. I., Zhang, L., Tassone, F. & Hagerman, R. J. Fragile X-associated tremor\/ataxia syndrome (FXTAS) in grey zone carriers. Clin. Genet. 84, 74\u201377 (2013).","journal-title":"Clin. Genet."},{"key":"77762_CR79","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12883-017-1009-9","volume":"18","author":"G Aydin","year":"2018","unstructured":"Aydin, G. et al. Frequency of SCA8, SCA10, SCA12, SCA36, FXTAS and C9orf72 repeat expansions in SCA patients negative for the most common SCA subtypes. BMC Neurol. 18, 3 (2018).","journal-title":"BMC Neurol."},{"key":"77762_CR80","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1093\/hmg\/10.14.1449","volume":"10","author":"A Kenneson","year":"2001","unstructured":"Kenneson, A., Zhang, F., Hagedorn, C. H. & Warren, S. T. Reduced FMRP and increased FMR1 transcription is proportionally associated with CGG repeat number in intermediate-length and premutation carriers. Hum. Mol. Genet. 10, 1449\u20131454 (2001).","journal-title":"Hum. Mol. Genet."},{"key":"77762_CR81","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1136\/jmg.2006.043950","volume":"44","author":"DZ Loesch","year":"2007","unstructured":"Loesch, D. Z. et al. Transcript levels of the intermediate size or grey zone fragile X mental retardation 1 alleles are raised, and correlate with the number of CGG repeats. J. Med. Genet. 44, 200\u2013204 (2007).","journal-title":"J. Med. Genet."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77762-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77762-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77762-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T05:03:52Z","timestamp":1730437432000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77762-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,1]]},"references-count":81,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["77762"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-77762-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,1]]},"assertion":[{"value":"28 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26257"}}